BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 7545240)

  • 1. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys).
    Wakefield JK; Wolf AG; Morrow CD
    J Virol; 1995 Oct; 69(10):6021-9. PubMed ID: 7545240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.
    Wakefield JK; Rhim H; Morrow CD
    J Virol; 1994 Mar; 68(3):1605-14. PubMed ID: 7508999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
    Kang SM; Wakefield JK; Morrow CD
    Virology; 1996 Aug; 222(2):401-14. PubMed ID: 8806524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.
    Li X; Mak J; Arts EJ; Gu Z; Kleiman L; Wainberg MA; Parniak MA
    J Virol; 1994 Oct; 68(10):6198-206. PubMed ID: 7521916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).
    Das AT; Klaver B; Berkhout B
    J Virol; 1995 May; 69(5):3090-7. PubMed ID: 7707537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
    Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
    Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).
    Wakefield JK; Kang SM; Morrow CD
    J Virol; 1996 Feb; 70(2):966-75. PubMed ID: 8551637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met).
    Kang SM; Zhang Z; Morrow CD
    J Virol; 1997 Jan; 71(1):207-17. PubMed ID: 8985340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA.
    Liang C; Rong L; Morin N; Cherry E; Huang Y; Kleiman L; Wainberg MA
    J Virol; 1997 Dec; 71(12):9075-86. PubMed ID: 9371564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription.
    Rhim H; Park J; Morrow CD
    J Virol; 1991 Sep; 65(9):4555-64. PubMed ID: 1714513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription.
    Zhang Z; Kang SM; Li Y; Morrow CD
    RNA; 1998 Apr; 4(4):394-406. PubMed ID: 9630246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases.
    Arts EJ; Stetor SR; Li X; Rausch JW; Howard KJ; Ehresmann B; North TW; Wöhrl BM; Goody RS; Wainberg MA; Grice SF
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10063-8. PubMed ID: 8816751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription.
    Isel C; Marquet R; Keith G; Ehresmann C; Ehresmann B
    J Biol Chem; 1993 Dec; 268(34):25269-72. PubMed ID: 7503978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementarity between 3' terminal nucleotides of tRNA and primer binding site is a major determinant for selection of the tRNA primer used for initiation of HIV-1 reverse transcription.
    Yu Q; Morrow CD
    Virology; 1999 Feb; 254(1):160-8. PubMed ID: 9927583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the interaction between tRNA and primer binding site from characterization of a unique HIV-1 virus which stably maintains dual PBS complementary to tRNA(Gly) and tRNA(His).
    Li Y; Zhang Z; Kang SM; Buescher JL; Morrow CD
    Virology; 1997 Nov; 238(2):273-82. PubMed ID: 9400600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA(His).
    Li Y; Zhang Z; Wakefield JK; Kang SM; Morrow CD
    J Virol; 1997 Sep; 71(9):6315-22. PubMed ID: 9261348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.
    Jiang M; Mak J; Ladha A; Cohen E; Klein M; Rovinski B; Kleiman L
    J Virol; 1993 Jun; 67(6):3246-53. PubMed ID: 8497049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective replication in human immunodeficiency virus type 1 when non-primers are used for reverse transcription.
    Wei M; Cen S; Niu M; Guo F; Kleiman L
    J Virol; 2005 Jul; 79(14):9081-7. PubMed ID: 15994802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of HIV type 1 proviral genomes that contain two distinct primer-binding sites.
    Li Y; Kang SM; Morrow CD
    AIDS Res Hum Retroviruses; 1997 Feb; 13(3):253-62. PubMed ID: 9115813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.